Cytodyn INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQB
CYDY
Cytodyn INCCytoDyn Inc. announced a $30 million standby equity purchase agreement with Yorkville Advisors Global to provide flexible capital for working capital and general corporate purposes.
OQB
CYDY
Cytodyn INCCytoDyn Inc. reports significant progress in its leronlimab oncology program, particularly in mTNBC and mCRC, alongside the closure of SEC and DOJ investigations.
OQB
CYDY
Cytodyn INCCytoDyn Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, executive compensation, and a significant increase in authorized common stock.
OQB
CYDY
Cytodyn INCCytoDyn Inc. will hold its 2024 Annual Meeting of Stockholders virtually on November 22, 2024, to vote on the election of directors, ratification of auditors, and executive compensation.